A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer

Clinical trial NCT04999605 · TERMINATED

Trial details

NCT number: NCT04999605
Sponsor: Akeso
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Recurrent Ovarian Carcinoma Relapsed Ovarian Cancer Ovarian Cancer

Start date: 2021-06-24
Primary completion: 2022-06-10
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.